Day 1 – Clinical Aspects of Breast Density
7:00 AM
Registration & Breakfast
7:15 AM
Welcome
Opening Oli Chant
Kalani Brady | Native Hawaiian Health, JABSOM, University of Hawaiʻi
Introduction
Co-Director John Shepherd, PhD | UH Cancer Center
9:15 AM
Clinical Aspects I
Moderator: Steve CummingsClinical Aspects Talk 1
Risk-Based Screening: When to Start and When to Use Supplemental Imaging Based on Breast Density and Risk
Diana Miglioretti, PhD | Department of Public Health Sciences, University of California, Davis
Clinical Aspects Talk 2
MRI screening and interval cancers (DENSE)
Carla van Gils, PhD | Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
Clinical Aspects Talk 3
Breast cancer risk models that combine a polygenic risk score, mammographic density and endogenous hormones
Susan Hankinson, ScD | School of Public Health and Health Sciences, University of Massachusetts
9:45 AM
Coffee Break
11:45 AM
Clinical Aspects II
Moderator: Gertraud MaskarinecClinical Aspects Talk 4
The Measurement Challenge – International case-control study of mammographic measures that predict breast cancer risk
Jennifer Stone, PhD | Centre for Genetic Origins of Health and Disease, University of Western Australia
Clinical Aspects Talk 5
Factors that change breast density and impact breast cancer risk
Per Hall, MD, PhD | Karolinska Institute
Clinical Aspects Talk 6
Dense Breast Legislation: What does it mean for patients and providers?
Christine Gunn, PhD | Women’s Health Unit, General Internal Medicine, Boston University School of Medicine
12:45 PM
Lunch
Hula Performance
Wahine Hula Akala
1:25 PM
Clinical Aspects II (cont.)
Moderator: Gertraud MaskarinecClinical Aspects Talk 7
Breast MRI Background Parenchymal Enhancement: Emerging Risk and Response Imaging Biomarker
Vignesh Arasu, MD, PhD | Kaiser Permanente Vallejo Medical Center
2:00 PM
Break
7:30 PM
Afternoon Networking Activities
UH Cancer Center Tours
2:30 PM, 3:30 PM / van or walk
Magic Island Picnic Networking Reception
4:00 PM – 7:30 PM / van or walk
Day 2 – Breast Density Workshop
8:00 AM
Registration & Breakfast
Breakout Discussion
8:15 AM
Housekeeping
9:35 AM
Biology and Characteristics
Moderator: Per HallPlenary Talk 1
Morphometric features of benign breast tissue: Implications for breast cancer risk
Lynn Chollet-Hinton, PhD | Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Poster Talk 1
Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing diagnostic image-guided breast biopsy
Clara Bodelon, PhD | National Cancer Institute
Poster Talk 2
Opportunities and Challenges for the Identification of Histological Correlates of Mammographic Density in Patients with Benign Breast Disease
Maeve Mullooly, PhD | Royal College of Surgeons in Ireland
10:05 AM
Coffee Break
11:25 AM
Biology and Characteristics (cont.)
Moderator: Per HallPlenary Talk 2
Breast density research in diverse populations and health disparities
Parisa Tehranifar, DrPH | Mailman School of Public Health, Columbia University Medical Center
Plenary Talk 3
Mammographic breast density and cancer risk in Asian women
Soo-Hwang Teo, MD | Breast Cancer Research Programme, Cancer Research Malaysia
12:25 PM
Lunch
1:10 PM
Poster Session 1 – Even-Numbered
2:10 PM
Methods
Moderator: John ShepherdPlenary Talk 4
A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction
Regina Barzilay, PhD | Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology
Poster Talk 3
Portable spectroscopic device an alternative method to measure Breast Density at young ages and large population studies. Pilot Study.
Ana Pereira, PhD | Institute of Nutrition and Food Technology, University of Chile
2:40 PM
Coffee Break
4:00 PM
Methods (cont.)
Moderator: John ShepherdPlenary Talk 5
Machine Learning and Texture Features
Sue Astley, PhD | Division of Informatics, Imaging and Data Science, Faculty of Medicine, Biology and Health, University of Manchester
Poster Talk 4
New mammography-based measures of breast cancer risk
John Hopper, PhD, NHMRC Senior Principal Research Fellow | School of Population and Global Health, University of Melbourne
Poster Talk 5
AI-based quantitative breast density assessment using transmission ultrasound
Bilal Malik, PhD | QT Ultrasound Labs
4:30 PM
Break
8:00 PM
Diamond Head Luau Networking Event
Day 3 – Breast Cancer Risk Assessment
8:00 AM
Registration & Breakfast
Breakout Discussion
8:15 AM
Housekeeping
9:35 AM
Risks Assessment I
Moderator: Karla KerlikowskePlenary Talk 6
Obesity and Breast Cancer Risk: The Multiethnic Story of Hawaii
Gertraud Maskarinec, MD, PhD | University of Hawaiʻi Cancer Center
Poster Talk 6
A Clinical Model for Assessing the Individual Breast Cancer Risk in Mammography Screening
Mikael Eriksson, PhD | Department of Medical Epidemiology and Biostatistics, Karolinska Institute
Poster Talk 7
Birth cohort effect on breast density of Dutch women
George Napolitano | Department of Public Health, University of Copenhagen
10:05 AM
Coffee Break
11:25 AM
Risks Assessments I (cont.)
Moderator: Karla KerlikowskePlenary Talk 7
Digital breast tomosynthesis mammography and cancer detection – the To-Be trial
Solveig Hofvind, PhD | Cancer Registry of Norway, Oslo Metropolitan University
Poster Talk 8
Impact of Breast Density Legislation on Ultrasound Use, 2002-2016
Katherine Callaway, PhD | Harvard Medical School/Harvard Pilgrim Healthcare Institute
12:25 PM
Lunch
1:25 PM
Poster Session 2 – Odd-Numbered
2:25 PM
Risks Assessments II
Moderator: Nico KarssemeijerPlenary Talk 8
Women Informed to Screen Depending On Measured of Risk (WISDOM): A Randomized Trial of Risk Assessment to Guide Breast Cancer Screening
Jeffrey Tice, MD | University of California, San Francisco
Poster Talk 9
Alterations in Levels of Serum IGF-I and IGBFP-3 and Ultrasound Tomography Measures of Breast Density Following Tamoxifen Therapy
Gretchen Gierach, PhD | National Cancer Institute
2:55 PM
Coffee Break
3:55 PM
Risks Assessments II (cont.)
Moderator: Nico KarssemeijerPoster Talk 10
Statins and Metformin Use and Mammographic Breast Density
Erica Lee Argov | Mailman School of Public Health, Columbia University
Plenary Talk 9
Combined screening with mammography and ultrasound in a population-based breast cancer screening program
Wolfgang Buchberger, MD, MSc | Institute of Quality and Efficiency in Medicine, UMIT
4:25 PM